Clinically probable RBD is an early predictor of malignant non-motor Parkinson’s disease phenotypes
Abstract Non-motor symptoms (NMS) in Parkinson’s disease (PD) significantly impact quality of life, especially in later stages. REM sleep behavior disorder (RBD) affects approximately 42% of all PD patients and frequently precedes motor PD symptoms. RBD is linked to increased rates of depression and...
Saved in:
Main Authors: | Alfonso Enrique Martinez-Nunez, Hunter Hutchinson, Patricia Coutinho, Filipe Pereira Sarmento, Venkat Srikar Lavu, Qingqi Yuan, Jagan Mohan Reddy Dwarampudi, Aysegul Gunduz, Gregory M. Pontone, Michael S. Okun, Joshua K. Wong |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-025-00874-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
by: Ching-Wen Hou, et al.
Published: (2025-01-01) -
REM Sleep Behavior Disorder (RBD) in Dementia with Lewy Bodies (DLB)
by: Po-Chi Chan, et al.
Published: (2018-01-01) -
Validity and reliability of the Turkish version of the Innsbruck RBD-9 diagnostic inventory (IRBD-9-TR)
by: Kezban Aslan-Kara, et al.
Published: (2025-01-01) -
RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2
by: Rang Feng, et al.
Published: (2025-02-01) -
ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics
by: Lennox Chitsike, et al.
Published: (2021-01-01)